These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31066571)

  • 1. Department of Defense end-of-season influenza vaccine effectiveness estimates for the 2017-2018 season.
    Coleman R; Eick-Cost AA; Hawksworth AW; Hu Z; Lynch L; Myers CA; DeMarcus L; Federinko S
    MSMR; 2018 Oct; 25(10):16-20. PubMed ID: 31066571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief report: Department of Defense midseason estimates of vaccine effectiveness for the 2018-2019 influenza season.
    Lynch LC; Coleman R; DeMarcus L; Scheckelhoff M; Eick-Cost AA; Hu Z; Hansen CJ; Graf PCF; Myers CA; Federinko S; Johnson A
    MSMR; 2019 Jul; 26(7):24-27. PubMed ID: 31347373
    [No Abstract]   [Full Text] [Related]  

  • 3. Department of Defense mid-season vaccine effectiveness estimates for the 2019-2020 influenza season.
    Thervil JW; DeMarcus LS; Eick-Cost A; Hu Z; Myers CA; Hollis EM; Balansay-Ames MS; Ellis K; Christy NC
    MSMR; 2021 Jun; 28(6):16-19. PubMed ID: 34379381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-season influenza vaccine effectiveness 2011-2012: a Department of Defense Global, Laboratory-based, Influenza Surveillance System case-control study estimate.
    MacIntosh VH; Tastad KJ; Eick-Cost AA
    Vaccine; 2013 Mar; 31(13):1651-5. PubMed ID: 23395733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of the 2018-2019 influenza season among Department of Defense service members and other beneficiaries.
    Eick-Cost AA; Ying S; Hu Z
    MSMR; 2020 Jun; 27(6):3-7. PubMed ID: 32589440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DoD Global, Laboratory-based, Influenza Surveillance Program: summary for the 2013-2014 influenza season.
    DeMarcus LS; Parms TA; Thervil JW
    MSMR; 2016 Mar; 23(3):2-5. PubMed ID: 27030925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory pathogen surveillance trends and influenza vaccine effectiveness estimates for the 2018-2019 season among Department of Defense beneficiaries.
    Kersellius GD; Gruner WE; Fries AC; DeMarcus LS; Robbins AS
    MSMR; 2020 Jan; 27(1):17-23. PubMed ID: 32023072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza Surveillance Trends and Influenza Vaccine Effectiveness Among Department of Defense Beneficiaries During the 2019-2020 Influenza Season.
    Hu W; Gruner WE; DeMarcus LS; Thervil JW; Kwaah B; Fries AC; Sjoberg PA; Robbins AS
    MSMR; 2021 Mar; 28(3):2-8. PubMed ID: 33773566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method.
    Vilcu AM; Souty C; Enouf V; Capai L; Turbelin C; Masse S; Behillil S; Valette M; Guerrisi C; Rossignol L; Blanchon T; Lina B; Hanslik T; Falchi A
    Clin Microbiol Infect; 2018 Apr; 24(4):431.e5-431.e12. PubMed ID: 28899840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance snapshot: Influenza vaccine effectiveness, U.S. European Command, as estimated by the Department of Defense Global, Laboratory-Based Influenza Surveillance Program, 2016-2017 influenza season.
    Shoubaki LA; DeMarcus L
    MSMR; 2017 Oct; 24(10):22. PubMed ID: 29077424
    [No Abstract]   [Full Text] [Related]  

  • 13. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.
    Flannery B; Chung JR; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Foust A; Sessions W; Berman L; Barnes JR; Spencer S; Fry AM
    MMWR Morb Mortal Wkly Rep; 2018 Feb; 67(6):180-185. PubMed ID: 29447141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief report: Department of Defense Global, Laboratory-based Influenza Surveillance Program's influenza vaccine effectiveness estimates and surveillance trends for 2016-2017 influenza season.
    Shoubaki LA
    MSMR; 2018 Jan; 25(1):8-9. PubMed ID: 29381077
    [No Abstract]   [Full Text] [Related]  

  • 16. Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated.
    Ohmit SE; Petrie JG; Malosh RE; Johnson E; Truscon R; Aaron B; Martens C; Cheng C; Fry AM; Monto AS
    J Infect Dis; 2016 Apr; 213(8):1229-36. PubMed ID: 26597255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.
    Pebody R; Andrews N; McMenamin J; Durnall H; Ellis J; Thompson CI; Robertson C; Cottrell S; Smyth B; Zambon M; Moore C; Fleming DM; Watson JM
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early estimates of seasonal influenza vaccine effectiveness--United States, January 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jan; 62(2):32-5. PubMed ID: 23325354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15.
    Leval A; Hergens MP; Persson K; Örtqvist Å
    Euro Surveill; 2016 Oct; 21(43):. PubMed ID: 27813473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.